Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
TearScience
Develops an office-based medical device to treat dry eye syndrome
Morrisville, NC
Contact:
Immanuel Thangaraj
Acquisition
Acquired by: Johnson & Johnson
Exit date: August 04, 2017
Related News
TearScience®, Inc. Secures $44.5 Million to Commercialize Breakthrough Treatment for Dry Eye